Avanafil NEW

Introduction

Avanafil is an orally selective phosphodiesterase 5 inhibitor. Clinical trials in phases I, II, and III have demonstrated that Avanafil, when used to treat erectile dysfunction, has the advantages of rapid onset, shorter duration of action, and fewer adverse reactions compared to other phosphodiesterase 5 inhibitors. Additionally, Avanafil has shown to have favorable clinical efficacy and safety.

Usage

Avanafil is a phosphodiesterase-5 (PDE5) inhibitor utilized in the treatment of erectile dysfunction.